Bank of Montreal Can Purchases 12,765 Shares of Natus Medical Inc (BABY)

Bank of Montreal Can grew its position in shares of Natus Medical Inc (NASDAQ:BABY) by 29.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 55,651 shares of the medical equipment provider’s stock after buying an additional 12,765 shares during the period. Bank of Montreal Can owned 0.17% of Natus Medical worth $1,984,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Eagle Asset Management Inc. lifted its holdings in Natus Medical by 246.5% during the 2nd quarter. Eagle Asset Management Inc. now owns 1,801,275 shares of the medical equipment provider’s stock worth $62,143,000 after purchasing an additional 1,281,395 shares in the last quarter. Carillon Tower Advisers Inc. purchased a new stake in Natus Medical during the 2nd quarter worth about $41,626,000. BlackRock Inc. lifted its holdings in Natus Medical by 10.8% during the 2nd quarter. BlackRock Inc. now owns 4,793,172 shares of the medical equipment provider’s stock worth $165,363,000 after purchasing an additional 466,409 shares in the last quarter. First Wilshire Securities Management Inc. purchased a new stake in Natus Medical during the 2nd quarter worth about $2,307,000. Finally, Voce Capital Management LLC lifted its holdings in Natus Medical by 9.7% during the 2nd quarter. Voce Capital Management LLC now owns 725,109 shares of the medical equipment provider’s stock worth $25,016,000 after purchasing an additional 64,308 shares in the last quarter. 95.86% of the stock is currently owned by hedge funds and other institutional investors.

A number of brokerages recently issued reports on BABY. ValuEngine cut Natus Medical from a “hold” rating to a “sell” rating in a report on Saturday. BidaskClub raised Natus Medical from a “hold” rating to a “buy” rating in a report on Thursday, August 2nd. Zacks Investment Research raised Natus Medical from a “sell” rating to a “hold” rating in a report on Friday, August 10th. Finally, Roth Capital set a $36.00 price objective on Natus Medical and gave the stock a “buy” rating in a report on Thursday, October 25th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. Natus Medical presently has an average rating of “Hold” and an average price target of $42.50.

Shares of BABY opened at $29.95 on Friday. The stock has a market cap of $1.05 billion, a P/E ratio of 20.66 and a beta of 0.54. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.31 and a current ratio of 3.21. Natus Medical Inc has a 52-week low of $27.69 and a 52-week high of $42.80.

Natus Medical (NASDAQ:BABY) last issued its quarterly earnings data on Wednesday, October 24th. The medical equipment provider reported $0.40 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.02). The company had revenue of $130.60 million for the quarter, compared to analysts’ expectations of $132.92 million. Natus Medical had a positive return on equity of 11.34% and a negative net margin of 3.53%. The business’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same period last year, the company posted $0.40 EPS. As a group, research analysts expect that Natus Medical Inc will post 1.48 EPS for the current year.

In other Natus Medical news, insider Jonathan Kennedy sold 47,600 shares of the company’s stock in a transaction dated Thursday, August 30th. The stock was sold at an average price of $36.85, for a total value of $1,754,060.00. Following the transaction, the insider now directly owns 161,628 shares in the company, valued at approximately $5,955,991.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 5.50% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: “Bank of Montreal Can Purchases 12,765 Shares of Natus Medical Inc (BABY)” was reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.americanbankingnews.com/2018/11/10/bank-of-montreal-can-purchases-12765-shares-of-natus-medical-inc-baby-2.html.

About Natus Medical

Natus Medical Incorporated provides newborn care, neurology, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.

Recommended Story: What is Cost of Debt?

Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Inc (NASDAQ:BABY).

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply